Standard Biotools Inc
(LAB)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2016 | 09-2016 | 06-2016 | 03-2016 | 12-2015 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -75,985 | -58,289 | -38,501 | -19,884 | -53,315 |
| Depreciation Amortization | 18,216 | 13,372 | 8,845 | 4,365 | 16,115 |
| Accounts receivable | 10,521 | 12,073 | 6,011 | 5,532 | -2,762 |
| Accounts payable and accrued liabilities | -2,271 | -1,443 | -980 | -1,601 | 769 |
| Other Working Capital | 4,712 | 4,884 | 6,509 | 3,783 | -8,271 |
| Other Operating Activity | 5,669 | 995 | 2,970 | 13 | 12,731 |
| Operating Cash Flow | $-39,138 | $-28,408 | $-15,146 | $-7,792 | $-34,733 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -5,065 | -4,371 | -2,662 | -1,144 | -3,982 |
| Purchase Of Investment | -38,594 | -38,564 | -34,559 | -8,514 | -66,973 |
| Sale Of Investment | 88,761 | 74,252 | 58,717 | 30,862 | 103,369 |
| Purchase Sale Intangibles | N/A | N/A | N/A | N/A | -6,670 |
| Other Investing Activity | 0 | 0 | 0 | 0 | -6,670 |
| Investing Cash Flow | $45,102 | $31,317 | $21,496 | $21,204 | $25,744 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 227 | 217 | 134 | 5 | 5,491 |
| Other Financing Activity | -111 | -90 | 0 | 0 | -151 |
| Financing Cash Flow | $116 | $127 | $134 | $5 | $5,340 |
| Exchange Rate Effect | -152 | 153 | 297 | 320 | -947 |
| Beginning Cash Position | 29,117 | 29,117 | 29,117 | 29,117 | 33,713 |
| End Cash Position | 35,045 | 32,306 | 35,898 | 42,854 | 29,117 |
| Net Cash Flow | $5,928 | $3,189 | $6,781 | $13,737 | $-4,596 |
| Free Cash Flow | |||||
| Operating Cash Flow | -39,138 | -28,408 | -15,146 | -7,792 | -34,733 |
| Capital Expenditure | -5,065 | -4,371 | -2,662 | -1,144 | -3,982 |
| Free Cash Flow | -44,203 | -32,779 | -17,808 | -8,936 | -38,715 |